The Australian Securities and Investments Commission is investigating alleged suspicious trading in the run-up to the announcement of a takeover at Australian supplement firm Vitaco.
Australian manufacturer of pharmaceutical grade cannabis and hemp-based products Creso Pharma has sealed deals to launch its nutraceuticals in two European markets.
China has provided one of the few positive notes in Mead Johnson’s quarterly results, with bosses hailing “substantial progress” in the country, despite conceding that global growth would be slower than planned.
Net profits at Australian vitamin and supplement supplier Blackmores fell by 46.6% in the first quarter, with daigou sales – items bought by Chinese entrepreneurs in Australia to ship back to China – plummeting.
A joint venture between Blackmores and Bega Cheese to supply infant formula across APAC - and in particular China - has missed its sales targets, hitting Bega’s financial performance.
GNC could become the latest vitamin and supplement firm to have Chinese owners, with The Wall Street Journal reporting that the company has met with several interested parties.
In the first instalment of NutraIngredients–Asia's Business Monitor, we keep tabs on the latest developments at the region’s leading nutrition and supplement firms, featuring Blackmores, Swisse Wellness and Ausnutria.
The Japanese economy may be sluggish, but the country’s health food, nutrition and functional foods sectors are holding steady, with 10 key trends affecting the market.
The sports nutrition potential of New Zealand blackcurrants, the superfood status of Canadian maple syrup and the functional benefits of Canadian barley – these were three of the high-profile pitches at the HI Japan tradeshow from international organisations seeking...
Indian companies Vitalic Health and Athena Life Sciences have signed a joint venture to launch nutraceuticals and dietary supplements under the brand name 'Truuth'.
In the first of a two-part interview, DuPont’s Asia president for health and nutrition Dr Li Yongjing discusses the initial turbulence created by the ongoing merger with Dow, and explains why he believes the new relationship will make the firm better...
The rise of China’s functional food and dietary supplement industry is continuing to outstrip overall economic growth, and will continue to do so with sports nutrition and goods for the elderly likely to drive future increases.
The food industry needs to stop looking at challenges such as obesity, malnutrition and waste as costly challenges and see them as the opportunities for creating “$2 trillion of added value” as it strives to increase global production by 70% before 2050.
New Zealand’s a2 Milk Company has signalled its intention to branch out from infant formula into a broader range of dairy-based nutritional products – with the burgeoning China market very much in its sights.
Sales at Chinese infant nutrition firm Biostime dropped by 14% in the first half of 2016 to RMB1.46bn (US$220m), with the Biostime brand – which accounts for 86% of the company’s sales – down 5.4% and the value brand Adimil down 65.7%.
Australian nutraceutical firm Gordagen Pharmaceuticals is preparing to launch its heart health and endurance products in the US by the end of the year.
Implementing stringent safety and quality regulations, tackling micronutrient deficiencies and maximising the opportunities from inward investment need to be three of key priorities for the food industry in India, amid projections of a doubling of production...
Shanghai Pharmaceuticals Holding Co Ltd and private equity firm Primavera Capital is to buy Australian vitamin manufacturer Vitaco Holdings for US$239m.